Cell-based therapy for insulin-dependent diabetes mellitus

European Journal of Endocrinology

Volumn 138, Issue 2, 1998, Pages 129-133

  Efrat, Shimon ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; HUMAN; HUMAN CELL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW;

ADENOVIRIDAE; ANIMALS; CELL TRANSFORMATION, VIRAL; DIABETES MELLITUS, TYPE 1; FORECASTING; GENETIC VECTORS; HUMANS; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031951829     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1380129     Document Type: Review

References (39)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 977-986.
2. Kolodka TM, Finegold M, Moss L & Woo SL. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proceedings of the National Academy of Sciences of the USA 1995 92 3293-3297.
3. Lipes MA, Cooper EM, Skelly R, Rhodes CJ, Boschetti E, Weir GC et al. Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proceedings of the National Academy of Sciences of the USA 1996 93 8595-8600.
4. Holz GG & Habener JF. Signal transduction crosstalk in the endocrine system: pancreatic β cells and the glucose competence concept. Trends in Biochemical Sciences 1992 17 388-393.
5. Chick WL, Warren S, Chute RN, Like AA, Lauris V & Kitchen KC. A transplantable insulinoma in the rat. Proceedings of the National Academy of Sciences of the USA 1977 74 628-630.
6. Santerre RF, Cook RA, Crisel RMD, Sharp JD, Schidt RJ, Williams DC et al. Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proceedings of the National Academy of Sciences of the USA 1981 78 4339-4342.
7. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S et al. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proceedings of the National Academy of Sciences of the USA 1988 85 9037-9041.
8. D'Ambra R, Surana M, Efrat S, Starr RG & Fleischer N. Regulation of insulin secretion from B-cell lines derived from transgenic mice insulinomas resembles that of normal B-cells. Endocrinology 1990 126 2815-2822.
9. Miyazaki J-I, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y et al. Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 1990 127 126-132.
10. Hamaguchi K, Gaskins HR & Leiter EH. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes 1991 40 842-849.
11. Asfari M, Janjic D, Meda P, Li G, Halban PA & Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 1992 130 167-178.
12. Radvanyi F, Christgau S, Baekkeskov S, Jolicoeur C & Hanahan D. Pancreatic β cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Molecular and Cellular Biology 1993 13 4223-4232.
13. Wang S, Beattie GM, Mally MI, Cirulli V, Itkin-Ansari P, Lopez AD et al. Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplantation 1997 6 59-67.
14. Cooper DK, Koren E & Oriol R. Oligosaccharides and discordant xenotransplantation. Immunology Review 1994 141 31-58.
15. Schmoeckel M, Nollert G, Shahmohammadi M, Young VK, Chavez G, Kasper-Konig W et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 1996 62 729-734.
16. Clark SA, Quaade C, Constandy H, Hansen P, Halban P, Ferber S et al. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 1997 46 958-967.
17. Efrat S, Leiser M, Surana M, Tal M, Fusco-DeMane D & Fleischer N. Murine insulinoma cell line with normal glucose-regulated insulin secretion. Diabetes 1993 42 901-907.
18. Knaack D, Fiore DM, Surana M, Leiser M, Laurence ME, Fusco-DeMane D et al. Clonal insulinoma cell line which stably maintains correct glucose responsiveness. Diabetes 1994 43 1413-1417.
19. Efrat S, Fusco-DeMane D, Lemberg H, Emran OA & Wang S. Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proceedings of the National Academy of Sciences of the USA 1995 92 3576-3580.
20. Hanahan D. Heritable formation of pancreatic B-cell tumours in transgenic mice expressing recombinant insulin simian virus 40 oncogenes. Nature 1985 315 115-122.
21. Gossen M & Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the USA 1992 89 5547-5551.
22. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W & Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995 268 1766-1769.
23. Aebischer P, Schluep M, Deglon N, Joseph J-M, Hirt L, Heyd B et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Medicine 1996 2 696-699.
24. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA & Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990 249 1293-1295.
25. Posselt AM, Odorico JS, Barker CF & Naji A. Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone marrow. Diabetes 1992 41 771-775.
26. Lau HT, Yu M, Fontana A & Stoeckert CJ. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996 273 109-112.
27. Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Winn KJ et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 1996 61 997-1004.
28. Wold WSM & Gooding LR. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991 184 1-8.
29. 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 1989 342 435-438.
30. 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proceedings of the National Academy of Sciences of the USA 1989 86 8932-8935.
31. Markmann JF, Bassiri H, Desai NM, Odorico JS, Kim JI, Koller BH et al. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation 1992 54 1085-1089.
32. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP & Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes 1993 42 1520-1527.
33. Faustman D & Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991 252 1700-1702.
34. Wold WSM. Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. Journal of Cell Biochemistry 1993 53 329-335.
35. Efrat S, Fejer G, Brownlee M & Horwitz MS. Prolonged survival of murine pancreatic islet allografts mediated by adenovirus early region 3 immunoregulatory transgenes. Proceedings of the National Academy of Sciences of the USA 1995 92 6947-6951.
36. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR & Bennink JR. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 1990 247 715-718.
37. Beier DC, Cox JH, Vining DR, Cresswell P & Engelhard VH. Association of human class I MHC alleles with the adenovirus E3/19K protein. Journal of Immunology 1994 152 3862-3872.
38. von Herrath MG, Efrat S, Oldstone MBA & Horwitz MS. Expression of adenoviral E3 transgenes in β cells prevents autoimmune diabetes. Proceedings of the National Academy of Sciences of the USA 1997 94 9808-9813.
39. Ilan Y, Droguett G, Roy Chowdhury N, Li Y, Sengupta K, Thummala NR et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proceedings of the National Academy of Sciences of the USA 1997 94 2587-2592.